National Cholesterol Education Program. Second Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II).

HomeCirculationVol. 89, No. 3National Cholesterol Education Program. Second Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). Free AccessAbstractAboutSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessAbstractNational Cholesterol Education Program. Second Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). Originally published1 Mar 1994https://doi.org/10.1161/01.CIR.89.3.1333Circulation. 1994;89:1333–1445"National Cholesterol Education Program. Second Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II).." Circulation, 89(3), pp. 1333–1445 Previous Back to top Next FiguresReferencesRelatedDetailsCited By Babaeva N, Belenkaya L, Sholokhov L, Atalyan A and Suturina L (2022) Uterine fibroid and its association with metabolic syndrome in women of reproductive age (literature review), Acta Biomedica Scientifica, 10.29413/ABS.2022-7.5-1.4, 7:5-1, (27-34) El Meouchy P, Wahoud M, Allam S, Chedid R, Karam W and Karam S (2022) Hypertension Related to Obesity: Pathogenesis, Characteristics and Factors for Control, International Journal of Molecular Sciences, 10.3390/ijms232012305, 23:20, (12305) Worm N, Weingärtner O, Schulze C and Lechner K (2021) Gesättigte Fettsäuren und kardiovaskuläres RisikoSaturated fatty acids and cardiovascular risk, Herz, 10.1007/s00059-021-05067-6, 47:4, (354-365), Online publication date: 1-Aug-2022. Hodkinson A, Tsimpida D, Kontopantelis E, Rutter M, Mamas M and Panagioti M (2022) Comparative effectiveness of statins on non-high density lipoprotein cholesterol in people with diabetes and at risk of cardiovascular disease: systematic review and network meta-analysis, BMJ, 10.1136/bmj-2021-067731, (e067731) Göktaş Z, Dikmen D and Rakıcıoğlu N (2021) Validation of MEDFICTS Dietary Assessment Questionnaire in Turkish Population, Public Health Nutrition, 10.1017/S1368980021002299, 25:1, (13-17), Online publication date: 1-Jan-2022. Singh R, Smail M, Rai R, Maheshwari A, Verma N and Isaza A (2022) Effects of fenugreek seeds on cardiovascular diseases and other chronic diseases Functional Foods and Nutraceuticals in Metabolic and Non-Communicable Diseases, 10.1016/B978-0-12-819815-5.00036-7, (399-410), . Panbehkar-Jouybari M, Mollahosseini M, Salehi-Abargouei A, Fallahzadeh H, Mirzaei M and Hosseinzadeh M (2021) The Mediterranean diet and dietary approach to stop hypertension (DASH)-style diet are differently associated with lipid profile in a large sample of Iranian adults: a cross-sectional study of Shahedieh cohort, BMC Endocrine Disorders, 10.1186/s12902-021-00856-w, 21:1 Debus E, Espinola-Klein C, Honig S, Behrendt C and Bauersachs R (2021) Antithrombotische Therapie der peripheren arteriellen VerschlusskrankheitAntithrombotic treatment of peripheral arterial occlusive disease, Gefässchirurgie, 10.1007/s00772-021-00786-w, 26:5, (415-428), Online publication date: 1-Sep-2021. Miklishanskaya S, Solomasova L and Mazur N (2021) Types of obesity and their prognostic value, Obesity Medicine, 10.1016/j.obmed.2021.100350, 25, (100350), Online publication date: 1-Aug-2021. Miklishanskaya S and Mazur N (2021) Types of obesity and their impact on long-term outcomes in patients with cardiovascular disease, Obesity and metabolism, 10.14341/omet12367, 18:2, (125-131) Guerrero-Martínez F (2021) Racionalidad científica para la evolución de las metas de LDL-c, Cardiovascular and Metabolic Science, 10.35366/100794, 32:S3, (182-191), . Rhee E (2021) Understanding of Clinical Practice Guidelines for Dyslipidemia Stroke Revisited: Dyslipidemia in Stroke, 10.1007/978-981-16-3923-4_13, (145-151), . Chuang-Stein C and Kirby S (2021) Designing Phase 4 Trials Quantitative Decisions in Drug Development, 10.1007/978-3-030-79731-7_10, (163-176), . Kim K, Yoon J, Won K, Lim S, Chae I, Lee S, Kim S and Kim H (2020) Assessment of the Efficacy of Lowering LDL Cholesterol with Rosuvastatin 10 mg in Four Korean Statin Benefit Groups as per ACC/AHA Guidelines (NewStaR4G), Journal of Clinical Medicine, 10.3390/jcm9040916, 9:4, (916) Miklishanskaya S, Solomasova L and Mazur M (2020) Obesity and Mechanisms of its Negative Impact on the Cardiovascular System, Rational Pharmacotherapy in Cardiology, 10.20996/1819-6446-2020-02-09, 16:1, (108-117) HATA K, Sayaka T, TAKAHASHI M, SASAKI A, UMEKAWA Y, MIYASHITA K, OGURA K, TOSHIMA G, MAEDA M, TAKAHASHI J and KAKUNI M (2020) Lipoprotein profile and lipid metabolism of PXB-cells®, human primary hepatocytes from liver-humanized mice: proposal of novel in vitro system for screening anti-lipidemic drugs, Biomedical Research, 10.2220/biomedres.41.33, 41:1, (33-42), Online publication date: 1-Feb-2020. Tuttolomondo A, Di Raimondo D, Casuccio A, Velardo M, Salamone G, Cataldi M, Corpora F, Restivo V, Pecoraro R, Della Corte V, Maida C, Simonetta I, Cirrincione A, Vassallo V and Pinto A (2020) Mediterranean diet adherence and congestive heart failure: Relationship with clinical severity and ischemic pathogenesis, Nutrition, 10.1016/j.nut.2019.110584, 70, (110584), Online publication date: 1-Feb-2020. Levinson S (2019) Non–High-Density Lipoprotein Cholesterol and Guidelines for Cholesterol Lowering in Recent History, Laboratory Medicine, 10.1093/labmed/lmz032, 51:1, (14-23), Online publication date: 2-Jan-2020. Silaruks S, Sriratanasathavorn C, Rawdaree P, Kunjara-Na-Ayudhaya R, Thinkhamrop B and Sritara P (2019) Prevalence of Dyslipidemia and Goal Attainment with Lipid-Lowering Therapy: Insights from Thai Multicenter Study and Overview of the Major Guidelines Dyslipidemia, 10.5772/intechopen.82355 Frank U, Nikol S, Belch J, Boc V, Brodmann M, Carpentier P, Chraim A, Canning C, Dimakakos E, Gottsäter A, Heiss C, Mazzolai L, Madaric J, Olinic D, Pécsvárady Z, Poredoš P, Quéré I, Roztocil K, Stanek A, Vasic D, Visonà A, Wautrecht J, Bulvas M, Colgan M, Dorigo W, Houston G, Kahan T, Lawall H, Lindstedt I, Mahe G, Martini R, Pernod G, Przywara S, Righini M, Schlager O and Terlecki P (2019) ESVM Guideline on peripheral arterial disease, Vasa, 10.1024/0301-1526/a000834, 48:Supplement 102, (1-79), Online publication date: 1-Dec-2019. Anholm C, Kumarathurai P, Pedersen L, Samkani A, Walzem R, Nielsen O, Kristiansen O, Fenger M, Madsbad S, Sajadieh A and Haugaard S (2019) Liraglutide in combination with metformin may improve the atherogenic lipid profile and decrease C-reactive protein level in statin treated obese patients with coronary artery disease and newly diagnosed type 2 diabetes: A randomized trial, Atherosclerosis, 10.1016/j.atherosclerosis.2019.07.007, 288, (60-66), Online publication date: 1-Sep-2019. Cao J and Devaraj S (2019) Recent AHA/ACC guidelines on cholesterol management expands the role of the clinical laboratory, Clinica Chimica Acta, 10.1016/j.cca.2019.04.002, 495, (82-84), Online publication date: 1-Aug-2019. Rosenblit P (2019) Extreme Atherosclerotic Cardiovascular Disease (ASCVD) Risk Recognition, Current Diabetes Reports, 10.1007/s11892-019-1178-6, 19:8, Online publication date: 1-Aug-2019. Leppert M, Poisson S, Sillau S, Campbell J, Ho P and Burke J (2019) Is Prevalence of Atherosclerotic Risk Factors Increasing Among Young Adults? It Depends on How You Ask, Journal of the American Heart Association, 8:6, Online publication date: 19-Mar-2019. Levinson S (2019) Critical review of 2016 ACC guidelines on therapies for cholesterol lowering with reference to laboratory testing, Clinica Chimica Acta, 10.1016/j.cca.2017.11.001, 489, (189-195), Online publication date: 1-Feb-2019. Saraswathy K, Joshi S, Yadav S and Garg P (2018) Metabolic distress in lipid & one carbon metabolic pathway through low vitamin B-12: a population based study from North India, Lipids in Health and Disease, 10.1186/s12944-018-0748-y, 17:1, Online publication date: 1-Dec-2018. Hoffmann M (2018) Towards a More Personalized Treatment of Dyslipidemias to Prevent Cardiovascular Disease, Current Cardiology Reports, 10.1007/s11886-018-0996-5, 20:7, Online publication date: 1-Jul-2018. Monnier L, Colette C, El Azrak A, Rochd D, Essekkat N and Bakri A (2018) Avant-propos Ars longa… iudicium difficile . L’exemple des recommandations dans les dyslipidémies du diabétique, Médecine des Maladies Métaboliques, 10.1016/S1957-2557(18)30055-5, 12:3, (248-254), Online publication date: 1-May-2018. Baligar B, Hiregoudar N, S.S P, Cholenahalli M and Bande U (2018) NON-INVASIVE PREDICTORS AND PREVALENCE OF LEFT MAIN OR TRIPLE VESSEL DISEASE IN PATIENT WITH CORONARY ARTERY DISEASES, Journal of Evidence Based Medicine and Healthcare, 10.18410/jebmh/2018/89, 5:5, (439-445), Online publication date: 29-Jan-2018. Nannucci S, Rinnoci V, Pracucci G, MacKinnon A, Pescini F, Adib-Samii P, Bianchi S, Dotti M, Federico A, Inzitari D, Markus H, Pantoni L and Fuh J (2018) Location, number and factors associated with cerebral microbleeds in an Italian-British cohort of CADASIL patients, PLOS ONE, 10.1371/journal.pone.0190878, 13:1, (e0190878) Singh S, Kaur N and Sharma R (2018) WAIST-HIP RATIO AND WAIST CIRCUMFERENCE AS SIMPLE MEASURES OF CARDIOVASCULAR RISK ASSESSMENT AND WEIGHT MANAGEMENT AMONG MEDICAL STUDENTS, Journal of Evidence Based Medicine and Healthcare, 10.18410/jebmh/2018/49, 5:3, (237-242), Online publication date: 11-Jan-2018. Okamura T, Sugiyama D, Hirata T, Kuwabara K and Hirata A (2018) Lipids and Cardiovascular Diseases: Epidemiologic Perspectives Encyclopedia of Cardiovascular Research and Medicine, 10.1016/B978-0-12-809657-4.99596-6, (221-229), . Okamura T (2018) OBSOLETE: Lipids and Cardiovascular Diseases: Epidemiologic Perspectives Reference Module in Biomedical Sciences, 10.1016/B978-0-12-801238-3.99596-5, . Tsai I, Wang C, Lu Y, Hung W, Wu C, Lu L, Chung F, Hsu C, Lee Y and Yu T (2017) The burden of major adverse cardiac events in patients with coronary artery disease, BMC Cardiovascular Disorders, 10.1186/s12872-016-0436-7, 17:1, Online publication date: 1-Dec-2017. Teng H and Chen L (2017) α-Glucosidase and α-amylase inhibitors from seed oil: A review of liposoluble substance to treat diabetes, Critical Reviews in Food Science and Nutrition, 10.1080/10408398.2015.1129309, 57:16, (3438-3448), Online publication date: 2-Nov-2017. Wang Y, Koh W, Talaei M, Yuan J and Pan A (2016) Association between the ratio of triglyceride to high-density lipoprotein cholesterol and incident type 2 diabetes in Singapore Chinese men and women, Journal of Diabetes, 10.1111/1753-0407.12477, 9:7, (689-698), Online publication date: 1-Jul-2017. Barth S, Zacher M, Reinecke H, Hautmann M, Kerber S, Gietzen F, Halbfass P, Schade A, Deneke T, Schieffer B and Hamm K (2017) Decreasing incidence of coronary heart disease in extreme obesity (BMI ≥ 40)—A single centre experience, Obesity Research & Clinical Practice, 10.1016/j.orcp.2016.08.007, 11:4, (435-444), Online publication date: 1-Jul-2017. Jellinger P, Handelsman Y, Rosenblit P, Bloomgarden Z, Fonseca V, Garber A, Grunberger G, Guerin C, Bell D, Mechanick J, Pessah-Pollack R, Wyne K, Smith D, Brinton E, Fazio S, Davidson M, Jellinger P, Handelsman Y, Bell D, Bloomgarden Z, Brinton E, Davidson M, Fazio S, Fonseca V, Garber A, Grunberger G, Guerin C, Mechanick J, Pessah-Pollack R, Rosenblit P, Smith D, Wyne K, Bush M, Zangeneh F, Handelsman Y, Bell D, Bloomgarden Z, Brinton E, Fazio S, Fonseca V, Garber A, Grunberger G, Guerin C, Jellinger P, Rosenblit P, Smith D, Wyne K and Davidson M (2017) American Association of Clinical Endocrinologists and American College of Endocrinology Guidelines for Management of Dyslipidemia and Prevention of Cardiovascular Disease, Endocrine Practice, 10.4158/EP171764.APPGL, 23, (1-87), Online publication date: 1-Apr-2017. Pollin T, Ordovas J and Guevara-Cruz M (2017) Genetic Influences on Blood Lipids and Cardiovascular Disease Risk Nutrition in the Prevention and Treatment of Disease, 10.1016/B978-0-12-802928-2.00026-6, (571-593), . Liu J and Arredondo F (2017) Menopause Clinical Reproductive Medicine and Surgery, 10.1007/978-3-319-52210-4_9, (161-193), . Chuang-Stein C and Kirby S (2017) Designing Phase 4 Trials Quantitative Decisions in Drug Development, 10.1007/978-3-319-46076-5_10, (139-151), . Palomäki A, Hällberg V, Ala-Korpela M, Kovanen P and Malminiemi K (2016) Prompt impact of first prospective statin mega-trials on postoperative lipid management of CABG patients: a 20-year follow-up in a single hospital, Lipids in Health and Disease, 10.1186/s12944-016-0292-6, 15:1, Online publication date: 1-Dec-2016. Eapen D, Schultz W, Heinl R, Ghasemzadeh N, Varghese T, Kurian D, Mathai C, Sandesara P, Kindya B, Allard-Ratick M, Bhatia N, Isiadinso I and Sperling L (2016) Primary Prevention of Cardiovascular Disease, Cardiovascular Innovations and Applications, 10.15212/CVIA.2016.0032, 1:4, Online publication date: 1-Sep-2016. Markossian T, Burge N, Ling B, Schneider J, Pacold I, Bansal V, Leehey D, Stroupe K, Chang A and Kramer H (2016) Controversies Regarding Lipid Management and Statin Use for Cardiovascular Risk Reduction in Patients With CKD, American Journal of Kidney Diseases, 10.1053/j.ajkd.2015.12.030, 67:6, (965-977), Online publication date: 1-Jun-2016. Thompson P (2016) Editorial Commentary: The metabolic syndrome: What does the clinician need to know and do?, Trends in Cardiovascular Medicine, 10.1016/j.tcm.2015.11.001, 26:4, (374-375), Online publication date: 1-May-2016. Wierzbicki A and Watts G (2015) The hinterland of familial hypercholesterolaemia, Current Opinion in Lipidology, 10.1097/MOL.0000000000000238, 26:6, (475-483), Online publication date: 1-Dec-2015. Brown W (2015) From the Editor: Is a goal a target?, Journal of Clinical Lipidology, 10.1016/j.jacl.2015.10.004, 9:6, (727-730), Online publication date: 1-Nov-2015. Tuttolomondo A, Casuccio A, Buttà C, Pecoraro R, Di Raimondo D, Della Corte V, Arnao V, Clemente G, Maida C, Simonetta I, Miceli G, Lucifora B, Cirrincione A, Di Bona D, Corpora F, Maugeri R, Iacopino D and Pinto A (2015) Mediterranean Diet in patients with acute ischemic stroke: Relationships between Mediterranean Diet score, diagnostic subtype, and stroke severity index, Atherosclerosis, 10.1016/j.atherosclerosis.2015.09.017, 243:1, (260-267), Online publication date: 1-Nov-2015. Bartsch E, Park A, Kingdom J, Ray J and Zenclussen A (2015) Risk Threshold for Starting Low Dose Aspirin in Pregnancy to Prevent Preeclampsia: An Opportunity at a Low Cost, PLOS ONE, 10.1371/journal.pone.0116296, 10:3, (e0116296) Colic M, Pantovic S, Jeremic M, Jokovic V, Obradovic Z and Rosic M (2015) Transport of Low-Density Lipoprotein Into the Blood Vessel Wall During Atherogenic Diet in the Isolated Rabbit Carotid Artery, Circulation Journal, 10.1253/circj.CJ-14-1316, 79:8, (1846-1852), . Nannucci S, Pescini F, Bertaccini B, Bianchi S, Ciolli L, Valenti R, Dotti M, Federico A, Inzitari D and Pantoni L (2014) Clinical, familial, and neuroimaging features of CADASIL-like patients, Acta Neurologica Scandinavica, 10.1111/ane.12284, 131:1, (30-36), Online publication date: 1-Jan-2015. Niranjana Murthy H and Meenakshi M (2015) Comparison between ANN-Based Heart Stroke Classifiers Using Varied Folds Data Set Cross-Validation Intelligent Computing, Communication and Devices, 10.1007/978-81-322-2012-1_74, (693-699), . Komori T, Eguchi K, Kabutoya T, Ishikawa J, Hoshide S and Kario K (2014) Left ventricular diastolic function evaluated by the E/e’ ratio is impaired in patients with masked uncontrolled hypertension, Clinical and Experimental Hypertension, 10.3109/10641963.2014.881839, 36:8, (538-544), Online publication date: 1-Dec-2014. Grundy S (2014) Cholesterol Management in Older Persons, The American Journal of Medicine, 10.1016/j.amjmed.2014.07.037, 127:12, (1140-1141), Online publication date: 1-Dec-2014. Foody J, Toth P, Tershakovec A, Musliner T, Tomassini J, Lowe R, Neff D and Davis H (2017) Efficacy and safety of ezetimibe plus atorvastatin therapy, Clinical Lipidology, 10.2217/clp.14.36, 9:4, (441-470), Online publication date: 1-Aug-2014. Franklin B, Durstine J, Roberts C and Barnard R (2014) Impact of diet and exercise on lipid management in the modern era, Best Practice & Research Clinical Endocrinology & Metabolism, 10.1016/j.beem.2014.01.005, 28:3, (405-421), Online publication date: 1-Jun-2014. Hussein L, Abdel-Rahim E, Afify A, El-Arab A and Labib E (2014) Effectiveness of Apricots (Prunus armeniaca), Pomegranate (Punica granatum) Juice and Lactic Acid Fermented Sobya on Plasma Levels of Lipid Profile Parameters and Total Homocysteine among Egyptian Adults, Food and Nutrition Sciences, 10.4236/fns.2014.522236, 05:22, (2225-2236), . Nitta K (2014) Dyslipidemia and Chronic Kidney Disease Management of Chronic Kidney Disease, 10.1007/978-3-642-54637-2_6, (71-82), . Acharjee S, Boden W, Hartigan P, Teo K, Maron D, Sedlis S, Kostuk W, Spertus J, Dada M, Chaitman B, Mancini G and Weintraub W (2013) Low Levels of High-Density Lipoprotein Cholesterol and Increased Risk of Cardiovascular Events in Stable Ischemic Heart Disease Patients, Journal of the American College of Cardiology, 10.1016/j.jacc.2013.07.051, 62:20, (1826-1833), Online publication date: 1-Nov-2013. Sales M, Sóter M, Candido A, Fernandes A, Oliveira F, Ferreira A, Sousa M, Ferreira C and Gomes K (2013) Correlation between plasminogen activator inhibitor-1 (PAI-1) promoter 4G/5G polymorphism and metabolic/proinflammatory factors in polycystic ovary syndrome, Gynecological Endocrinology, 10.3109/09513590.2013.819086, 29:10, (936-939), Online publication date: 1-Oct-2013. Abboud H, Labreuche J, Arauz A, Bryer A, Lavados P, Massaro A, Collazos M, Steg P, Yamout B, Vicaut E and Amarenco P (2012) Demographics, Socio-Economic Characteristics, and Risk Factor Prevalence in Patients with Non-Cardioembolic Ischaemic Stroke in Low- and Middle-Income Countries: The OPTIC Registry, International Journal of Stroke, 10.1111/j.1747-4949.2012.00893.x, 8:SA100, (4-13), Online publication date: 1-Oct-2013. Yilmaz-Aydogan H, Kurnaz O, Kucukhuseyin O, Akadam-Teker B, Kurt O, Eronat A, Tekeli A, Bugra Z and Ozturk O (2013) Different effects of PPARA, PPARG and ApoE SNPs on serum lipids in patients with coronary heart disease based on the presence of diabetes, Gene, 10.1016/j.gene.2013.03.136, 523:1, (20-26), Online publication date: 1-Jul-2013. Maron D, Hartigan P, Neff D, Weintraub W and Boden W (2013) Impact of Adding Ezetimibe to Statin to Achieve Low-Density Lipoprotein Cholesterol Goal (from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation [COURAGE] Trial), The American Journal of Cardiology, 10.1016/j.amjcard.2013.02.005, 111:11, (1557-1562), Online publication date: 1-Jun-2013. Zimmermann A, Grigorescu-Sido P, Rossmann H, Lackner K, Drugan C, Al Khzouz C, Bucerzan S, Naşcu I, Zimmermann T, Leucuţa D and Weber M (2012) Dynamic changes of lipid profile in Romanian patients with Gaucher disease type 1 under enzyme replacement therapy: a prospective study, Journal of Inherited Metabolic Disease, 10.1007/s10545-012-9529-3, 36:3, (555-563), Online publication date: 1-May-2013. D’Agostino Sr. R, Pencina M, Massaro J and Coady S (2013) Cardiovascular Disease Risk Assessment: Insights from Framingham, Global Heart, 10.1016/j.gheart.2013.01.001, 8:1, (11) Handattu S, Nayyar G, Garber D, Palgunachari M, Monroe C, Keenum T, Mishra V, Datta G and Anantharamaiah G (2013) Two apolipoprotein E mimetic peptides with similar cholesterol reducing properties exhibit differential atheroprotective effects in LDL-R null mice, Atherosclerosis, 10.1016/j.atherosclerosis.2012.10.064, 227:1, (58-64), Online publication date: 1-Mar-2013. Nseir W and Mahamid M (2013) Statins in Nonalcoholic Fatty Liver Disease and Steatohepatitis: Updated Review, Current Atherosclerosis Reports, 10.1007/s11883-012-0305-5, 15:3, Online publication date: 1-Mar-2013. Teramoto T, Sasaki J, Ishibashi S, Birou S, Daida H, Dohi S, Egusa G, Hiro T, Hirobe K, Iida M, Kihara S, Kinoshita M, Maruyama C, Ohta T, Okamura T, Yamashita S, Yokode M and Yokote K (2013) Diagnostic Criteria for Dyslipidemia, Journal of Atherosclerosis and Thrombosis, 10.5551/jat.17152, 20:8, (655-660), . Teramoto T (2013) Dietary Management in Japan Atherosclerosis Society (JAS) Guidelines for the Prevention of Atherosclerotic Cardiovascular Diseases in Japanese ^|^mdash;2012 Version^|^mdash;, The Japanese Journal of Nutrition and Dietetics, 10.5264/eiyogakuzashi.71.3, 71:1, (3-13), . (2013) KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease, Clinical and Molecular Hepatology, 10.3350/cmh.2013.19.4.325, 19:4, (325), . Takahashi E, Moriyama K and Yamakado M (2013) Status of Lipid Management Using Lifestyle Modification in Japanese Adults: An Analysis of the 2009 Japan Society of Ningen Dock Database, Internal Medicine, 10.2169/internalmedicine.52.9347, 52:15, (1681-1686), . Ryoo N, Yoon B, Yoon C, Ahn J, Choi J, Lim M, Kwon H, Park J, Lee J and Choi S (2013) Diffusion Tensor Imaging Changes Correlate with Clinical Progression in Vascular Mild Cognitive Impairment and Vascular Dementia of Subcortical Type, Dementia and Neurocognitive Disorders, 10.12779/dnd.2013.12.3.61, 12:3, (61), . Thayer J and Fischer J (2013) Heart rate variability, overnight urinary norepinephrine, and plasma cholesterol in apparently healthy human adults, International Journal of Cardiology, 10.1016/j.ijcard.2011.05.058, 162:3, (240-244), Online publication date: 1-Jan-2013. Jose M. O and Martha G (2013) Genetic Influences on Blood Lipids and Cardiovascular Disease Risk Nutrition in the Prevention and Treatment of Disease, 10.1016/B978-0-12-391884-0.00028-7, (519-540), . Liu J and Arredondo F (2013) Menopause Clinical Reproductive Medicine and Surgery, 10.1007/978-1-4614-6837-0_10, (139-161), . Miida T, Nishimura K, Okamura T, Hirayama S, Ohmura H, Yoshida H, Miyashita Y, Ai M, Tanaka A, Sumino H, Murakami M, Inoue I, Kayamori Y, Nakamura M, Nobori T, Miyazawa Y, Teramoto T and Yokoyama S (2012) A multicenter study on the precision and accuracy of homogeneous assays for LDL-cholesterol: Comparison with a beta-quantification method using fresh serum obtained from non-diseased and diseased subjects, Atherosclerosis, 10.1016/j.atherosclerosis.2012.08.022, 225:1, (208-215), Online publication date: 1-Nov-2012. Mannu G, Zaman M, Gupta A, Rehman H and Myint P (2014) Update on guidelines for management of hypercholesterolemia, Expert Review of Cardiovascular Therapy, 10.1586/erc.12.94, 10:10, (1239-1249), Online publication date: 1-Oct-2012. Jarvandi S, Joseph L, Gougeon R and Dasgupta K (2012) Vitamin supplementation and blood pressure in Type 2 diabetes, Diabetic Medicine, 10.1111/j.1464-5491.2012.03627.x, 29:10, (1253-1259), Online publication date: 1-Oct-2012. Nseir W, Diab H, Mahamid M, Abu-Elheja O, Samara M, Abid A and Mograbi J (2012) Randomised clinical trial: simvastatin as adjuvant therapy improves significantly the Helicobacter pylori eradication rate - a placebo-controlled study, Alimentary Pharmacology & Therapeutics, 10.1111/j.1365-2036.2012.05161.x, 36:3, (231-238), Online publication date: 1-Aug-2012. Vichiansiri R, Saengsuwan J, Manimmanakorn N, Patpiya S, Preeda A, Samerduen K and Poosiripinyo E (2012) The Prevalence of Dyslipidemia in Patients with Spinal Cord Lesion in Thailand, Cholesterol, 10.1155/2012/847462, 2012, (1-6), Online publication date: 10-Jul-2012. Nseir W, Mograbi J and Ghali M (2012) Lipid-Lowering Agents in Nonalcoholic Fatty Liver Disease and Steatohepatitis: Human Studies, Digestive Diseases and Sciences, 10.1007/s10620-012-2118-3, 57:7, (1773-1781), Online publication date: 1-Jul-2012. Jellinger P, Smith D, Mehta A, Ganda O, Handelsman Y, Rodbard H, Shepherd M and Seibel J (2012) American Association of Clinical Endocrinologists' Guidelines for Management of Dyslipidemia and Prevention of Atherosclerosis, Endocrine Practice, 10.4158/EP.18.S1.1, 18, (1-78), Online publication date: 1-Mar-2012. Roussell M, Hill A, Gaugler T, West S, Vanden Heuvel J, Alaupovic P, Gillies P and Kris-Etherton P (2012) Beef in an Optimal Lean Diet study: effects on lipids, lipoproteins, and apolipoproteins, The American Journal of Clinical Nutrition, 10.3945/ajcn.111.016261, 95:1, (9-16), Online publication date: 1-Jan-2012. JCS Joint Working Group (2012) Guidelines for Risks and Prevention of Sudden Cardiac Death (JCS 2010) - Digest Version -, Circulation Journal, 10.1253/circj.CJ-88-0022, 76:2, (489-507), . Chidrawar V, Patel K, Chitme H and Shiromwar S (2012) Pre–clinical evolutionary study of Clerodendrum phlomidis as an anti–obesity agent against high fat diet induced C57BL/6J mice, Asian Pacific Journal of Tropical Biomedicine, 10.1016/S2221-1691(12)60446-8, 2:3, (S1509-S1519), Online publication date: 1-Jan-2012. Remaley A, Rifai N and Warnick G (2012) Lipids, Lipoproteins, Apolipoproteins, and Other Cardiovascular Risk Factors Tietz Textbook of Clinical Chemistry and Molecular Diagnostics, 10.1016/B978-1-4160-6164-9.00027-5, (731-805), . Belski R (2012) Fiber, Protein, and Lupin-Enriched Foods: Role for Improving Cardiovascular Health Advances in Food and Nutrition Research Volume 66, 10.1016/B978-0-12-394597-6.00004-5, (147-215), . Shapira N (2012) A Gender-Specific Nutritional Approach to Women’s Healthcare Healthcare Overview, 10.1007/978-94-007-4602-2_15, (269-305), . Pita-Fernández S, Pértega-Díaz S, Valdés-Cañedo F, Seijo-Bestilleiro R, Seoane-Pillado T, Fernández-Rivera C, Alonso-Hernández A, Lorenzo-Aguiar D, López-Calviño B and López-Muñiz A (2011) Incidence of cardiovascular events after kidney transplantation and cardiovascular risk scores: study protocol, BMC Cardiovascular Disorders, 10.1186/1471-2261-11-2, 11:1, Online publication date: 1-Dec-2011. Koc G, Divrik T, Unlu N, Bulut V and Zorlu F (2011) Does cisplatin-based chemotherapy effect on blood lipid levels of patients with germ cell testicular tumor in long-term follow-up?, International Urology and Nephrology, 10.1007/s11255-011-9939-4, 43:4, (1095-1100), Online publication date: 1-Dec-2011. Khoueiry G, Waked A, Goldman M, El-Charabaty E, Dunne E, Smith M, Kleiner M, Lafferty J, Kalantar-Zadeh K and El-Sayegh S (2011) Dietary Intake in Hemodialysis Patients Does Not Reflect a Heart Healthy Diet, Journal of Renal Nutrition, 10.1053/j.jrn.2010.09.001, 21:6, (438-447), Online publication date: 1-Nov-2011. Puricel S, Adorjan P, Oberhänsli M, Stauffer J, Moschovitis A, Vogel R, Goy J, Müller O, Eeckhout E, Togni M, Wenaweser P, Meier B, Windecker S and Cook S (2011) Clinical outcomes after PCI for acute coronary syndrome in unprotected left main coronary artery disease: insights from the Swiss Acute Left Main Coronary Vessel Percutaneous Management (SALVage) study, EuroIntervention, 10.4244/EIJV7I6A112, 7:6, (697-704), Online publication date: 1-Oct-2011. Kumpatla S, Michael C and Viswanathan V (2011) Visceral Adiposity Index and pattern of dyslipidaemia at different stages of glucose intolerance—A study from India, Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 10.1016/j.dsx.2012.05.003, 5:4, (173-178), Online publication date: 1-Oct-2011. Mochari-Greenberger H, Terry M and Mosca L (2011) Sex, Age, and Race/Ethnicity Do Not Modify the Effectiveness of a Diet Intervention among Family Members of Hospitalized Cardiovascular Disease Patients, Journal of Nutrition Education and Behavior, 10.1016/j.jneb.2011.01.014, 43:5, (366-373), Online publication date: 1-Sep-2011. Nordmann A, Suter-Zimmermann K, Bucher H, Shai I, Tuttle K, Estruch R and Briel M (2011) Meta-Analysis Comparing Mediterranean to Low-Fat Diets for Modification of Cardiovascular Risk Factors, The American Journal of Medicine, 10.1016/j.amjmed.2011.04.024, 124:9, (841-851.e2), Online publication date: 1-Sep-2011. Anan K, Mitsuyama S, Yanagita Y, Kimura M, Doihara H, Komaki K, Kusama M and Ikeda T (2011) Effects of toremifene and anastrozole on serum lipids and bone metabolism in postmenopausal females with estrogen receptor–positive breast cancer: the results of a 2-year multicenter open randomized study, Breast Cancer Research and Treatment, 10.1007/s10549-011-1608-x, 128:3, (775-781), Online publication date: 1-Aug-2011. Zazpe I, Beunza J, Bes-Rastrollo M, Warnberg J, de la Fuente-Arrillaga C, Benito S, Vázquez Z and Martínez-González M (2011) Egg consumption and risk of cardiovascular disease in the SUN Project, European Journal of Clinical Nutrition, 10.1038/ejcn.2011.30, 65:6, (676-682), Online publication date: 1-Jun-2011. Cone C, Murata G and Myers O (2011) Demographic determinants of response to statin medications, American Journal of Health-System Pharmacy, 10.2146/ajhp100271, 68:6, (511-517), Online publication date: 15-Mar-2011. Berra K (2011) Does Nurse Case Management Improve Implementation of Guidelines for Cardiovascular Disease Risk Reduction?, Journal of Cardiovascular Nursing, 10.1097/JCN.0b013e3181ec1337, 26:2, (145-167), Online publication date: 1-Mar-2011. Maron D, Boden W, Weintraub W, Calfas K and O’Rourke R (2010) Is Optimal Medical Therapy as Used in the COURAGE Trial Feasible for Widespread Use?, Current Treatment Options in Cardiovascular Medicine, 10.1007/s11936-010-0104-7, 13:1, (16-25), Online publication date: 1-Feb-2011. Calan M, Calan O, Gonen M, Bilgir F, Kebapcilar L, Kulac E, Cinali T and Bilgir O (2011) Examination of Adhesion Molecules, Homocysteine and hs-CRP in Patients with Polygenic Hypercholesterolemia and Isolated Hypertriglyceridemia, Internal Medicine, 10.2169/internalmedicine.50.4297, 50:15, (1529-1535), . Kastelein J, Duivenvoorden R, Deanfield J, de Groot E, Jukema J, Kaski J, Münzel T, Taddei S, Lehner